Jeffrey Stein - 29 Dec 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: President & CEO, Director
Signature: /s/ Jeffrey Stein
Issuer symbol: CDTX
Transactions as of: 29 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 07 Jan 2022, 19:24:39 UTC
Previous filing: 15 Nov 2021
Next filing: 18 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Options Exercise	$0	+20,000	+4.3%	$0.000000	489,878	29 Dec 2021	Direct	F1, F2
holding	CDTX	Common Stock						231,602	29 Dec 2021	By trust
holding	CDTX	Common Stock						42,009	29 Dec 2021	By son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Restricted Stock Unit	Options Exercise	$0	-20,000	-50%	$0.000000	20,000	29 Dec 2021	Common Stock	20,000		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
F2	Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
F3	Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
F4	On January 31, 2019, the Reporting Person was granted restricted stock units totaling 60,000 shares subject to vesting upon the achievement of various milestones.